Amicus Therapeutics, Inc.
FOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $17,306 | -$24,420 | -$21,686 | $14,739 |
| Dep. & Amort. | $1,874 | $1,852 | $1,837 | $2,041 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $17,559 | $25,172 | $19,217 |
| Change in WC | -$9,885 | -$29,052 | $6,010 | -$43,739 |
| Other Non-Cash | $26,365 | $7,535 | -$3,575 | $3,826 |
| Operating Cash Flow | $35,660 | -$26,526 | $7,758 | -$3,916 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$382 | -$2,403 | -$212 | -$288 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18,173 | -$14,370 | -$38,810 | -$36,008 |
| Inv. Sales/Matur. | $17,256 | $10,995 | $6,161 | $15,904 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,299 | -$5,778 | -$32,861 | -$20,392 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$17 | -$8 | -$15 | -$43 |
| Stock Issued | $339 | $40 | $105 | $413 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,641 | -$432 | -$11,790 | $727 |
| Financing Cash Flow | -$1,319 | -$400 | -$11,700 | $1,097 |
| Forex Effect | -$1,191 | $9,987 | $4,819 | $3,107 |
| Net Chg. in Cash | $31,851 | -$22,717 | -$31,984 | -$20,104 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $158,702 | $184,732 | $216,716 | $236,820 |
| End Cash | $190,553 | $162,015 | $184,732 | $216,716 |
| Free Cash Flow | $35,278 | -$28,929 | $7,546 | -$4,204 |